# 바이오스페이스 일일 뉴스 리포트 - 2025년 11월 19일


## 주요 헤드라인

1. **Merck Extends Winrevair’s Win Streak With New Mid-Stage Data in Type of Hypertension (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/merck-extends-winrevairs-win-streak-with-mid-stage-in-underserved-type-of-hypertension>

2. **Merck Extends Winrevair’s Win Streak With New Mid-Stage Data in Type of Hypertension (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/merck-extends-winrevairs-win-streak-with-mid-stage-in-underserved-type-of-hypertension>

3. **Genmab Prunes Another ADC From $1.8B ProfoundBio Acquisition (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/genmab-prunes-another-adc-from-1-8b-profoundbio-acquisition>

4. **Nxera’s Quest for Profitability Claims 15% of Workforce (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/nxeras-quest-for-profitability-claims-15-of-workforce>

5. **Jazz, Zymeworks Bispecific Achieves ‘Practice-Changing’ Results in Stomach Cancer Study (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/jazz-zymeworks-bispecific-achieves-practice-changing-results-in-stomach-cancer-study>

6. **Before GLP-1s, a Great Pricing Battle Played Out in Hep C Market (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/before-glp-1s-a-great-pricing-battle-played-out-in-hep-c-market>

7. **Before GLP-1s, a Great Pricing Battle Played Out in Hep C Market (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/before-glp-1s-a-great-pricing-battle-played-out-in-hep-c-market>


---
*2025년 11월 19일 바이오스페이스 뉴스 피드에서 생성된 리포트*